Tegafur-Uracil versus 5-Fluorouracil in Combination with Cisplatin and Cetuximab in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Analysis

Tegafur-Uracil versus 5-Fluorouracil in Combination with Cisplatin and Cetuximab in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Analysis

There are increasing incidences of elderly patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, the treatment is not yet established. We conducted a propensity score matching analysis to evaluate the efficacy and safety of tegafur–uracil versus 5-fluorour...

Full description

Bibliographic Details
Main Authors: Meng-Che Hsieh, Chih-Chun Wang, Chuan-Chien Yang, Ching-Feng Lien, Chien-Chung Wang, Yu-Chen Shih, Shyh-An Yeh, Tzer-Zen Hwang
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Biology
Subjects:
elderly patients
recurrent or metastatic head and neck squamous cell carcinoma
tegafur–uracil
cetuximab
survival
Online Access:https://www.mdpi.com/2079-7737/10/10/1011

Internet

https://www.mdpi.com/2079-7737/10/10/1011

Similar Items